{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Although none of the provided abstracts directly examine LINC01024, the studies collectively illustrate that long non‐coding RNAs (lncRNAs) regulate key cellular processes that are likely to be mirrored by many uncharacterized lncRNAs such as LINC01024. For instance, one study demonstrated that LINC00152 is essential for proper mitotic progression by interacting with a network of M‐phase proteins; its depletion causes cells to arrest in prometaphase and ultimately compromises viability, indicating an oncogenic role in cell cycle control."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Similarly, another investigation of the novel lncRNA TALNEC2 revealed that lncRNAs can influence cell cycle transitions at the G1/S checkpoint while enhancing tumorigenicity, stemness, and therapy resistance in glioblastoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " By contrast, GASL1 acts as a brake on cell cycle progression and proliferation; its upregulation delays G1 exit, and its loss accelerates growth and tumor development, illustrating how lncRNAs can serve as tumor suppressors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, comprehensive reviews underscore that lncRNAs are central to multiple resistance mechanisms in breast cancer by modulating various pathways that confer treatment resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In the context of tumor immunology, lncRNAs have been implicated in orchestrating an immunosuppressive tumor microenvironment, and specific immune‐related lncRNA signatures have prognostic value in melanoma."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Finally, research on MA‐linc1 reveals that selective modulation of lncRNA expression can affect M phase exit and sensitize cancer cells to antimitotic drugs by derepressing tumor‐suppressive genes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Together, these studies highlight the multifaceted roles of lncRNAs in regulating cell cycle progression, tumor growth, and treatment resistance. They suggest that uncharacterized transcripts like LINC01024 may also be pivotal modulators of oncogenic processes and represent promising targets for therapeutic intervention.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Linda Nötzold, Lukas Frank, Minakshi Gandhi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-02357-0"}], "href": "https://doi.org/10.1038/s41598-017-02357-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28536419"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28536419"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Shlomit Brodie, Hae Kyung Lee, Wei Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15991"}], "href": "https://doi.org/10.18632/oncotarget.15991"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28423669"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28423669"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Lital Gasri-Plotnitsky, Aviv Ovadia, Katerina Shamalov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15864"}], "href": "https://doi.org/10.18632/oncotarget.15864"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28423601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28423601"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Alma D Campos-Parra, Eduardo López-Urrutia, Luz Tonantzin Orozco Moreno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms19092711"}], "href": "https://doi.org/10.3390/ijms19092711"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30208633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30208633"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ya Luo, Jiqiao Yang, Jing Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fonc.2020.00048"}], "href": "https://doi.org/10.3389/fonc.2020.00048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32083005"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32083005"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Fang-Wei Li, Sheng-Kang Luo "}, {"type": "b", "children": [{"type": "t", "text": "Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Gen Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/IJGM.S340025"}], "href": "https://doi.org/10.2147/IJGM.S340025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34880662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34880662"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Or Bida, Moriah Gidoni, Diana Ideses, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4944"}], "href": "https://doi.org/10.18632/oncotarget.4944"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26337085"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26337085"}]}]}]}